Skip to main content

Department of Pharmacology Archives

Neurofibromin fine-tunes bone growth

May. 6, 2015—The protein neurofibromin acts as a brake in a signaling pathway that is important in bone development, Vanderbilt researchers have discovered.

Read more


Lecture explores efforts to move pharmacogenetics into the clinic

Apr. 23, 2015—Preemptive genotyping: It sounds like a surprise attack, and it is.

Read more


Cancer signaling pathway blocker

Apr. 3, 2015—Researchers at Vanderbilt University have discovered a new way to inhibit Hedgehog (Hh) signaling, an important regulatory pathway for vertebrate development – and cancer.

Read more


Pharmacogenomics expert set for Wilkinson Lecture

Apr. 2, 2015—Mary Relling, Pharm.D., chair of the Department of Pharmaceutical Sciences at St. Jude Children’s Research Hospital in Memphis, will deliver this year’s Grant R. Wilkinson Distinguished Lecture in Clinical Pharmacology on Thursday, April 9.

Read more


New view of dopamine heteromers

Jan. 23, 2015—Although heteromeric dopamine receptors composed of both D1 and D2 subunits have been proposed to play a role in depression and schizophrenia, recent studies suggest these heteromers do not exist.

Read more


Does fish oil help prevent A-fib?

Jan. 9, 2015—Growing evidence suggests that fish oil, thought to directly prevent inflammation, oxidative stress and heart disease, may have limited clinical utility.

Read more


Atrial disease and hypertension links

Dec. 18, 2014—New findings suggest that misfolded proteins accumulate in the heart atria, particularly in patients with hypertension, and may contribute to atrial heart disease.

Read more


Bacterial secretion machinery: 3-D view

Dec. 11, 2014—New structural findings reveal how "gatekeeper" proteins participate in the secretion systems bacteria use to infect host cells.

Read more


Protein implicated in atherosclerosis

Nov. 25, 2014—Vanderbilt researchers have discovered a new target for the prevention of atherosclerotic plaque development and cardiovascular disease.

Read more


Nobel laureate sheds light on immune response system

Oct. 9, 2014—Peter Doherty, Ph.D., had some advice for young scientists at last week’s Flexner Discovery Lecture. The way to win a Nobel Prize, he said, “is to make a very big discovery first.”

Read more


Seizure mutation impairs receptor

Sep. 30, 2014—Defects in the production of certain receptors are linked to the pathogenesis of genetic epilepsies and fever-induced seizures.

Read more


Doherty set for next Discovery Lecture

Sep. 25, 2014—Nobel laureate Peter Doherty, Ph.D., who discovered how the immune system recognizes virus-infected cells, will deliver the next Flexner Discovery Lecture on Thursday, Oct. 2.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more